Ireland's HSE denies nearly 50% of applications for GLP-1 weight-loss medication coverage

The Health Service Executive (HSE) has rejected approximately half of all patient applications for state-funded access to weight-loss injections, citing strict clinical eligibility criteria. This high rejection rate highlights the tension between rising demand for obesity treatments and the fiscal constraints of the public health system.